Watch this for a minute . . . keep your blood vessels healthy life long !

https://drsvenkatesan.files.wordpress.com/2019/05/vid-20190504-wa0014-1.mp4   Yes, Its “evidence-based fun”. Forget all those anti-platelet trial dramas … showing in the cardiovascular theatres near you . There is only one genuine drug , that’s the good old humble Aspirin . Mind you ,none of other  actors can ever be imagined for primary prevention. By the way , there is absolutely no controversy for the role of Aspirin in secondary prevention after established CAD.(We know , how Aspirin has taken up a critically  Integral role in saving the life of the stents  as well as  patients,  post PCI) Oh , what a disgrace for this drug when it comes out of the glamorous cath lab zones. Its use is often frowned upon for preventing simple CAD. (All due to a single factor, fear of bleeding ? No , its exaggerated in most studies) Overlap between Primary and Secondary prevention  In primary prevention of CAD , what do we attempt to prevent? How do you differentiate established CAD from  “Established coronary atherosclerosis  but Non-established CAD ?” The fundamental flaw in this perceived controversy is in our inability to define what is significant CAD in the asymptomatic population.Do we need a clinical event to say, established CAD? For the attention of  evidence-based script writers , a long query  . . . “How much evidence we have to conclude , that a  patient with manifest clinical CAD carry more risk for a  recurrence  tha...
Source: Dr.S.Venkatesan MD - Category: Cardiology Authors: Tags: Uncategorized arrive and ascend study primary prevention of cad with aspirin Source Type: blogs